デフォルト表紙
市場調査レポート
商品コード
1410744

経カテーテル僧帽弁移植術(TMVI)の世界市場 - 市場規模(セグメント別)、シェア、規制、償還、処置、予測(~2033年)

Transcatheter Mitral Valve Implantation (TMVI) Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033

出版日: | 発行: GlobalData | ページ情報: 英文 | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.31円
経カテーテル僧帽弁移植術(TMVI)の世界市場 - 市場規模(セグメント別)、シェア、規制、償還、処置、予測(~2033年)
出版日: 2023年12月19日
発行: GlobalData
ページ情報: 英文
納期: 即納可能 即納可能とは
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界の経カテーテル僧帽弁移植術(TMVI)市場について調査分析し、各セグメントの市場規模、市場動向、競合情勢、COVID-19の影響などの情報を提供しています。

市場モデルの主な内容は以下の通りです。

上市済みの経カテーテル僧帽弁移植術(TMVI)と進化する競合情勢

  • 主な業界動向の考察
  • 経カテーテル僧帽弁移植術(TMVI)市場のセグメント別の年間収益と市場見通し(2015年~2033年)
  • セグメント別の総処置数、ユニット数、平均販売価格、市場金額に関する詳細なデータ

世界、地域、国レベルの市場固有の考察

  • 世界の動向を地域別に分類した定性的な市場固有の情報と国別の考察
  • 経カテーテル僧帽弁移植術(TMVI)市場のSWOT分析
  • 経カテーテル僧帽弁移植術(TMVI)市場の競合力学の考察と動向

医療制度の概要を含む真の全体像を把握することで、市場の理解を促進します。また、市場参入セグメントでは、償還政策や規制情勢についての情報を提供し、市場力学をより深く掘り下げることができます。

  • 国別の医療制度の概要
  • 国別の償還政策
  • 国別の医療技術に関する規制情勢

対象企業

  • Abbott Laboratories
図表

List of Tables

Not Applicable

List of Figures

Not Applicable

目次

Abstract

Transcatheter Mitral Valve Implantation (TMVI) Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Transcatheter Mitral Valve Implantation (TMVI) market for the year 2020 and beyond. Transcatheter Mitral Valve Implantation (TMVI) are used to treat aortic aneurysms and dissections. Aortic aneurysms can occur in both the thoracic aorta (Thoracic Aortic Aneurysms - TAA) and abdominal aorta (Abdominal Aortic Aneurysms - AAA). Aortic aneurysms occur when the walls of the aorta weaken, resulting in a large swelling and weakening of the aortic wall.

Abdominal Transcatheter Mitral Valve Implantation (TMVI) are used to treat abdominal aortic aneurysms by reinforcing a part of the aorta using a minimally invasive procedure. Thoracic Transcatheter Mitral Valve Implantation (TMVI) are used to treat thoracic aortic aneurysms by reinforcing a part of the aorta using a minimally invasive procedure. Leg extensions are additional extensions which are used in conjunction with the stent graft to extend the length of the stent graft.

Each of the covered 27 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Transcatheter Mitral Valve Implantation (TMVI) market and evolving competitive landscape -

  • Insightful review of the key industry trends.
  • Annualized total Transcatheter Mitral Valve Implantation (TMVI) market revenue by segment and market outlooks from 2015-2033.
  • Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

  • Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
  • SWOT analysis for Transcatheter Mitral Valve Implantation (TMVI) market.
  • Competitive dynamics insights and trends provided Transcatheter Mitral Valve Implantation (TMVI) market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Abbott Laboratories

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

  • CMO executives who must have deep understanding of the Transcatheter Mitral Valve Implantation (TMVI) marketplace to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

  • Understand the impact of COVID-19 on Transcatheter Mitral Valve Implantation (TMVI) market.
  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving Transcatheter Mitral Valve Implantation (TMVI) market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Transcatheter Mitral Valve Implantation (TMVI) market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track device sales in the global and country-specific Transcatheter Mitral Valve Implantation (TMVI) market from 2015-2033.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Table of Contents

Not Applicable